p40 protein subunit of IL-12 and IL-23 — Drug Target

All drugs that target p40 protein subunit of IL-12 and IL-23 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Interleukin-12 Antagonist [EPC]

Marketed (2)

• Stelara · Johnson & Johnson · Immunology
  Ustekinumab binds to the p40 subunit of IL-12 and IL-23, disrupting their signaling and reducing inflammation.
• STEQEYMA · CELLTRION, INC. · Interleukin-12 Antagonist [EPC] · Other
  Ustekinumab binds to the p40 subunit of IL-12 and IL-23, disrupting their signaling and reducing inflammation.